SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithkline Consumer reports 13% rise in Q2 net profit

01 Aug 2013 Evaluate

GlaxoSmithkline Consumer Healthcare has reported results for second quarter ended June 30, 2013.

The company has reported a rise of 12.53% in its net profit at Rs 119.96 crore for the quarter, as compared to Rs 106.60 crore for the same quarter in the previous year. Total income of the company has increased by 18.03% to Rs 928.83 crore for the quarter under review as compared to Rs 786.96 crore for the quarter ended June 30, 2012.

GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 485.10
Nestle 1378.70
Britannia Inds 5840.10
LT Foods 420.20
Hatsun Agro Product 980.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×